Endo sells American Medical Systems Men's and Prostate Health businesses to Boston Scientific

Endo International plc announced the completion of the previously announced sale of its American Medical Systems' (AMS) Men's and Prostate Health businesses to Boston Scientific for a purchase price of up to $1.65 billion, with $1.60 billion in cash having been paid by Boston Scientific to Endo at closing. As previously announced, Endo is also eligible to receive a potential milestone payment of $50 million in cash conditional on the achievement of certain product revenue milestones in the Men's Health and Prostate Health businesses in 2016.